Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

With a potential strike of Canada Post workers on the horizon, the Government of Saskatchewan is releasing its plans to ...

"I pretended to jot down notes, but I couldn’t shake the feeling that the family before me had so much in common with my own.

Drug Plan and Extended Benefits The Ministry of Health will ... delays will impact health card applications as well as orders for birth, death and marriage certificates. Visit eHealthsask.ca for ...

Revita has US FDA Breakthrough Device Designation in weight maintenance ... additional time may be required to develop and ...

Hemp retailers in Missouri are trying to work with state lawmakers to place regulations on an industry that still exists ...

Full raw materials traceability, allergen analysis, CoO, CoA, beta-lactam-free and animal origin-free certification ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

Brands marketing foods and ingredients for mood management must navigate a complex regulatory landscape by understanding ...

(RTTNews) - GE HealthCare Technologies Inc. (GEHC) Wednesday said that it has received FDA 510(k) clearance for its innovative SIGNA MAGNUS 3.0T high-performance, head-only magnetic resonance imaging ...

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared ...